Literature DB >> 20721877

Bowel dilation as a predictor of adverse outcome in isolated fetal gastroschisis.

L Garcia1, M Brizot, A Liao, M M Silva, A C Tannuri, M Zugaib.   

Abstract

OBJECTIVES: This study was designed to evaluate bowel diameter as a predictor of adverse outcome in isolated fetal gastroschisis.
METHODS: Retrospective study involving 94 singleton pregnancies. Ultrasound measurements of herniated bowel transverse diameter (BTD) were performed up to 3 weeks before delivery. Adverse outcome was intrauterine/neonatal death and/or bowel complications.
RESULTS: Last BTD was recorded at 35.6 ± 1.6 weeks and mean interval to delivery was 6.2 ± 5.0 days. Intrauterine/neonatal death occurred in 10 (10.6%) cases; bowel complications were observed in 8 (8.5%). BTD ≥ 15, ≥ 20, ≥ 25, and ≥ 30 mm were found in 87, 46, 13, and 4% of pregnancies with a favorable outcome, respectively. BTD ≥ 25 mm sensitivity was 38%, and positive and negative predictive values were 38 and 87%. For BTD ≥ 30 mm, the values were 19, 50, and 85%. Observed/expected BTD ROC curve showed an area of 0.67, best cut-off value at 1.39; prediction values were similar to those for BTD ≥ 25 mm. Bowel dilatation was also significantly associated with lower rate of primary surgical closure, longer period to full oral feeding, and prolonged hospital stay.
CONCLUSIONS: Bowel dilatation demonstrated up to 3 weeks before delivery is a predictor of intestinal complications and is associated with lower rate of primary surgical closure, longer period to achieve full oral feeding, and hospital stay.
© 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20721877     DOI: 10.1002/pd.2596

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  1 in total

Review 1.  Gastroschisis: antenatal sonographic predictors of adverse neonatal outcome.

Authors:  Rachael Page; Zachary Michael Ferraro; Felipe Moretti; Karen Fung Kee Fung
Journal:  J Pregnancy       Date:  2014-12-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.